Pages with the most revisions
Showing below up to 50 results in range #5,851 to #5,900.
- San Fang Chemical Industry Co., Ltd. (3 revisions)
- San Miguel Corporation (3 revisions)
- LiveCare, Inc. (3 revisions)
- Bourse Direct SA (3 revisions)
- Spyglass Resources Corp. (3 revisions)
- Pollard Banknote Limited (3 revisions)
- Bowman Consulting Group Ltd. (3 revisions)
- QKL Stores Inc. (3 revisions)
- Lumens Co., Ltd. (3 revisions)
- Lundin Mining Corporation (3 revisions)
- Avant Brands Inc. (3 revisions)
- XOMA Corporation (3 revisions)
- China South City Holdings Limited (3 revisions)
- Wabash National Corporation (3 revisions)
- Associated Capital Group, Inc. (3 revisions)
- Archaea Energy Inc. (3 revisions)
- EBay Inc. (3 revisions)
- Nuveen Core Equity Alpha Fund (3 revisions)
- Rogers Corporation (3 revisions)
- Metals Creek Resources Corp. (3 revisions)
- Gerdau S.A. (3 revisions)
- NCC AB (3 revisions)
- The Gabelli Global Utility (3 revisions)
- Edgewell Personal Care Company (3 revisions)
- Liquidity Services, Inc. (3 revisions)
- Technical Olympic S.A. (3 revisions)
- Northern 3 VCT PLC (3 revisions)
- Fuse Science, Inc. (3 revisions)
- Magyar Telekom Távközlési Nyilvánosan Müködö Részvénytársaság (3 revisions)
- Q-Soft Verwaltungs AG (3 revisions)
- Kutcho Copper Corp. (3 revisions)
- Prysmian S.p.A. (3 revisions)
- Koninklijke Vopak N.V. (3 revisions)
- Unibios Holdings S.A. (3 revisions)
- Airspan Networks Holdings Inc. (3 revisions)
- Aerie Pharmaceuticals, Inc. (3 revisions)
- Champions Oncology, Inc. (3 revisions)
- Soligenix, Inc. (3 revisions)
- Tower Properties Company (3 revisions)
- Kier Group plc (3 revisions)
- Kaman Corporation (3 revisions)
- BlackRock MuniYield Quality Fund, Inc. (3 revisions)
- Winnebago Industries, Inc. (3 revisions)
- Macquarie Global Infrastructure Total Return Fund Inc. (3 revisions)
- Rio Silver Inc. (3 revisions)
- Sky Light Holdings Limited (3 revisions)
- Marchex, Inc. (3 revisions)
- M3-Brigade Acquisition III Corp. (3 revisions)
- Q BioMed Inc. (3 revisions)
- Protalix BioTherapeutics, Inc. (3 revisions)